Amended Rules No. 736 “On the Rules of Evaluation of Medicines and Medical Devices” become effective on April 9, 2020.
The National Center for Expertise of Medicines and Medical Devices of the Republic of Kazakhstan announced that all applications for marketing authorisation will be accepted in accordance with the amended Rules No. 736 from now on.
The amendment affected Annexes 1 and 2 of the Rules, which establish the procedure of evaluation of medicines and medical devices. In particular, amended procedure establishes submission of the registration dossier through the information system of an expert organisation or the “electronic” government portal.
In case of questions and more information: